Background: Patients presenting with cam deformity of the femoral head and neck sustain repeated trauma to the articular cartilage of the superior acetabulum, with chondral delamination injuries found during hip arthroscopy. Two previous studies reveal conflicting chondrocyte viability data in these traumatic cartilage injuries. The full-thickness nature of flaps may suggest that chondrocytes residing in the cartilage flap matrix in the joint environment would remain viable despite shear trauma.
Full-thickness injury to the cartilage is commonly noted during hip arthroscopy. Up to 31.5% of patients with cam impingement, 9% of patients with pincer impingement, and 26% of patients with combined impingement demonstrate full-thickness acetabular rim articular cartilage flaps at the time of hip arthroscopy. 13 Specifically, cam impingement results in damage to the anterosuperior chondrolabral junction. Flexion of a nonspherical head leads to shear injury, which then leads to separation at the chondrolabral junction and the creation of an acetabular-based chondral flap. 2 While several chondral repair techniques have been described, 5, 9, 12, 14, 15 the ability of these techniques to treat full-thickness defects relies on viable chondrocytes being present in the flaps. Although 2 studies have examined the viability of the chondrocytes present in acetabularbased chondral flaps in the context of femoroacetabular impingement (FAI), results have been discordant, with reports of anywhere between 11% to more than 90% of chondrocytes being viable in a flap. 6, 10 The purpose of our study is to determine the in vivo tissue viability of acetabular full-thickness chondral flaps in patients with FAI when samples are analyzed immediately after biopsy. We hypothesized that the majority of the tissue in acetabular-based full-thickness chondral flaps would be viable in the joint microenvironment.
METHODS
This study was approved by our center's institutional review board. From October 2012 through March 2014, a single surgeon (V.J.W.) prospectively collected full-thickness acetabular cartilage flaps from consecutive patients. Inclusion criteria were patients undergoing hip arthroscopy with FAI with a full-thickness acetabular chondral flap. Exclusion criteria were revision surgery or previous hip surgery, as well as any evidence of osteoarthritis or rheumatologic disease. Ten consecutive patients meeting the inclusion criteria were included in our study.
After the establishment of the anterolateral and anterior portals, a standard diagnostic examination of the hip joint was performed. When acetabular chondral flaps were noted on diagnostic arthroscopy, they were gently probed to define the extent of the lesion, and the completely detached portion of the full-thickness chondral flap was sharply excised with an arthroscopic knife and removed from the joint in an atraumatic manner (Figure 1 ). Care was taken to avoid heat or crushing forces on the cartilage flap to avoid damage to the tissue. After removal of the flaps, all patients underwent microfracture of the subchondral bone underlying the full-thickness cartilage defect.
Samples were immediately placed in cold Hank's Balanced Salt Solution without phenol red solution (with 2% fetal bovine serum and penicillin/streptomycin) and were immediately transported to our laboratory. Sample processing began on their arrival to the laboratory. All samples were processed for live/dead cell staining within 2 hours from collection. The edge of each cartilage flap was trimmed, and flaps were further sectioned into 3 separate sections, 1 mm in thickness. Based on the size of the sample, 3 to 10 slices of tissue (20-50 mL thickness) were cut from random locations on the flap, and they were then gently washed with cold Hank's Balanced Salt Solution. Slices of the flap were then incubated with live/dead cell staining solution (LIVE/DEAD Viability/Cytotoxicity Assay Kit; Invitrogen) at room temperature for 30 minutes. Samples were then washed 3 times with phosphate-buffered solution, fixed with 4% paraformaldehyde solution, and evaluated under a microscope. Images were captured using confocal microscopy. Cell viability was determined using the per- 
Statistical Analysis
Demographic data were reported as a mean of the population with SD. Live chondrocytes are reported as a percentage of total chondrocytes noted in the samples. Correlation between the percentage of live chondrocytes and age, sex, and body mass index was done with a nonparametric Spearman rank correlation coefficient.
RESULTS
A total of 10 patients were included in this study, and no patients were excluded. Mean patient age was 36 6 11 years (range, 18-48 years), and 8 of 10 (80%) patients were male. The mean BMI was 28.9 6 5.6 kg/m Table 1 . The total proportion of live cells from all sections analyzed was 85.8%. The mean number of live cells per patient was 87% 6 10%. Furthermore, 6 patients had .90% live chondrocytes, and all patients had .64% live chondrocytes (Figure 2 ). There was a poor 
DISCUSSION
In patients who have FAI with full-thickness, delaminated acetabular chondral flaps, we found that 87% of chondrocytes are viable and that all patients had .64% live chondrocytes in delaminated flaps. Furthermore, we found that this relationship is not significantly related to patient age, sex, or BMI.
Meulenkamp et al 10 also evaluated chondrocyte viability in delaminated cartilage flaps. After excision of delaminated flaps during hip arthroscopy, the cartilage was prepared in formalin solution and embedded in paraffin, which allowed for staining with hematoxylin and eosin. The samples were then assessed for chondrocyte viability under light microscopy by counting the number of lacunae-containing viable cells within a nucleus absent of signs of cell degeneration and dividing this by the total number of cells, which is a method known as the ''empty lacunae'' technique. 11 They evaluated 12 chondral flaps from 11 patients and noted 90% cartilage viability, with 50% of flaps containing hyaline cartilage, 4 with mixed fibrocartilage and hyaline cartilage, and 2 with mainly fibrocartilage. While the results are similar to what was found in the current study, this study may underestimate the viability of the cartilage by using the empty lacunae technique to determinate viability. It is clear that the artefactual loss of staining of osteocytic/chondrocytic nuclei may result from suboptimal tissue fixation and could lead to an underestimation of chondrocyte viability. In addition, loss of chondrocytes is not complete until 2 to 4 weeks after the onset of cell damage, so this technique may underestimate the number of more recently lost chondrocytes. 7 Hariri et al 6 recently evaluated the chondrocyte viability of acetabular chondral flaps during hip arthroscopy. They found a mean cellular viability of 39% in their specimens; furthermore, only 2 of 10 specimens had .50% cell viability. This finding is remarkably different from what was discovered in the present study. A possible cause of this difference may lie within several methodological differences. The authors did not perform live/dead cell staining immediately after flap harvest, instead storing flaps in phosphatebuffered solution. Prolonged sample storage may affect cell viability. In addition, any time that was spent between cell staining and evaluation may result in further cell death. Further, tissue slides were cut before staining, which can result in damage to the cells at the edge of each slide before staining. Any of these differences could lead to an underestimation of the percentage of live chondrocytes in chondral acetabular flaps on final evaluation.
Full-thickness cartilage loss is a difficult problem for all active people but particularly in the young population in whom joint preservation is key. While debridement of the cartilage flaps and microfracture of the remaining subchondral bone are currently used, novel solutions that treat the en bloc cartilage flaps as donor tissue instead of refuse could provide superior alternatives for joint preservation. Obviously, the in vivo chondrocyte viability of the full-thickness delaminated cartilage injuries is critical. Several repair techniques have been described, including repair of the flap with fibrin glue 14, 15 and suture repair. 12 Furthermore, techniques using autologous chondrocyte scaffolds 5 and collagen membranes 9 have been described, while minced cartilage autograft may have a role in treating defects covered by flaps. 3 These techniques require a high density of chondrocytes to develop an adequate sample for implantation, as there is a linear relationship between the biosynthetic activity of the chondrocytes in culture and the initial sample. 1, 4, 8 Our results suggest that acetabular chondral flaps contain a majority of viable chondrocytes, and they may have the potential to be used in repair techniques or sent for culture expansion and reimplantation. Further studies may evaluate the use of the cartilage flaps for these purposes.
Several limitations of our study can be noted. First, our study has a small sample size, which does not allow for identification of subgroups for risk factors. Second, 8 of 10 patients included in this study are male. Acetabular chondral flaps are more common in cam-type FAI, and given that males more commonly experience this pattern of impingement, this sample may be reflective of the population as a whole. We are unable to fully describe the duration of symptoms, which may help represent the age of the cartilage flap and may play a role in the degree of chondrocyte viability within the flaps. Finally, while we demonstrate that the majority of chondrocytes are viable within acetabular chondral flaps, further study is required to discover the applicability of these findings for cartilage repair techniques.
CONCLUSION
We found that acetabular chondral flaps are composed of approximately 87% live cells when analyzed immediately after biopsy, with 6 of 10 patients having greater than 90% live cells. These data support an innovation pathway focused on salvaging the autologous cartilage tissue for repair or coupling it with future biologic and scaffold solutions to preserve the joints of active people.
